ENHANCEMENT OF THE ENDOTHELIAL PRODUCTION OF PROSTACYCLIN BY INHIBITORS OF PROTEIN-SYNTHESIS

被引：2

作者：

BOEYNAEMS, JM

BOUTHERINFALSON, O

LAGNEAU, C

GALAND, N

机构：

来源：

BRITISH JOURNAL OF PHARMACOLOGY | 1990年 / 101卷 / 04期

关键词：

D O I：

10.1111/j.1476-5381.1990.tb14160.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

1. Pretreatment of bovine aortic endothelial cells with cycloheximide enhanced their capacity to release prostacyclin in response to adenosine 5'-triphosphate (ATP) and bradykinin. 2. The action of cycloheximide was time-dependent; it became detectable after a 1 h exposure to the cells and was maximal after 3 h. 3. Puromycin mimicked the effect of cycloheximide. For these two agents, the enhancement of prostacyclin release was obtained at concentrations producing a partial inhibition of protein synthesis. 4. Cycloheximide increased the mobilization of free arachidonic acid induced by ATP in bovine aortic endothelial cells. 5. In conclusion, the synthesis of new proteins is not involved in the stimulatory action of ATP and bradykinin on prostacyclin production by bovine aortic endothelial cells. Despite the short half-life of prostaglandin H synthase in endothelial cells, cycloheximide and puromycin enhanced the release of prostacyclin induced by agonists. Our data suggest that this release might be under the control of rapidly turning-over phospholipase inhibitory proteins.

引用

页码：799 / 802

页数：4

共 21 条

[1]

BOEYNAEMS J.M., GALAND N., KETELBANT P., Prostacyclin production by the deendothelialized rabbit aorta, J. Clin. Invest, 76, pp. 7-14, (1985)

[2]

BOOYSE F.M., SEDLAK B.J., RAFELSSON M.E., Culture of arterial endothelial cells

[3]

characterization and growth of bovine aorta cells, Thromb. Diathes. Haemork, 34, pp. 825-839, (1975)

[4]

CARTER T.D., HALLAM T.J., CUSACK N.J., PEARSON J.D., Regulation of P2y‐purinoceptor‐mediated prostacyclin release from human endothelial cells by cytoplasmic calcium concentration, Br. J. Pharmacol, 95, pp. 1181-1190, (1988)

[5]

CAVENDER D., HASKARD D., FOSTER N., ZIFF M., Superinduction of T lymphocyte‐endothelial cell (EC) binding by treatment of EC with interleukin 1 and protein synthesis inhibitors, J. Immunol, 138, pp. 2149-2154, (1987)

[6]

COLDEN-STANFIELD M., SCHILLING W.P., RITCHIE A.K., ESKIN S.G., NAVARRO L.T., KUNZE D.L., Bradykinin‐induced increases in cytosolic calcium and ionic currents in cultured bovine aortic endothelial cells, Circ. Res, 61, pp. 632-640, (1987)

[7]

CLARK M.A., LITTLEJOHN D., MONG S., CROOKE S.T., Effect of leukotrienes, bradykinin and calcium ionophore A23187 on bovine endothelial cells: release of prostacyclin, Prostaglandins, 31, pp. 157-166, (1986)

[8]

CLARK M.A., LITTLEJOHN D., CONWAY T.M., MONG S., STEINER S., CROOKE S.T., Leukotriene D4 treatment of bovine aortic endothelial cells and murine smooth muscle cells in culture results in an increase in phospholipase A2 activity, J. Biol. Chem, 261, pp. 10713-10718, (1986)

[9]

DAVIDSON F.F., DENNIS E.A., POWELL M., GLENNEY J.R., Inhibition of phospholipase A2 by lipocortins and calpactins. An effect of binding to substrate phospholipids, J. Biol. Chem, 262, pp. 1698-1705, (1987)

[10]

DERIAN C.K., MOSKOWITZ M.A., Polyphosphoinositide hydrolysis in endothelial cells and carotid artery segments. Bradykinin‐2 receptor stimulation is calcium‐dependent, J. Biol. Chem, 261, pp. 3831-3837, (1986)

← 1 2 3 →